cromolyn sodium has been researched along with meclizine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cunha, FQ; Ferreira, SH; Parada, CA; Tambeli, CH | 1 |
2 other study(ies) available for cromolyn sodium and meclizine
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception.
Topics: Animals; Anti-Asthmatic Agents; Cimetidine; Cromolyn Sodium; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Indoles; Male; Meclizine; Neurons, Afferent; Nociceptors; p-Methoxy-N-methylphenethylamine; Pain; Pain Measurement; Piperazines; Pyrilamine; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Tropisetron | 2001 |